CARCINOID
Clinical trials for CARCINOID explained in plain language.
Never miss a new study
Get alerted when new CARCINOID trials appear
Sign up with your email to follow new studies for CARCINOID, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for gut cancer patients who failed standard therapy
Disease control Recruiting nowThis study tests a new drug called RYZ101 in people with advanced neuroendocrine tumors of the gut or pancreas that have grown after prior treatment with a standard radioactive therapy. The goal is to see if RYZ101 can slow tumor growth better than other available treatments. Abo…
Matched conditions: CARCINOID
Phase: PHASE3 • Sponsor: RayzeBio, Inc. • Aim: Disease control
Last updated May 17, 2026 05:34 UTC
-
Radioactive drug RYZ401 targets Hard-to-Treat tumors in first human trial
Disease control Recruiting nowThis early-stage study tests a new radioactive drug called RYZ401 in people with neuroendocrine tumors and other solid tumors that have a specific protein on their surface. The main goals are to find the safest dose and schedule, and to see if the drug can shrink tumors. About 10…
Matched conditions: CARCINOID
Phase: PHASE1 • Sponsor: RayzeBio, Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New pill aims to tame carcinoid syndrome symptoms
Disease control Recruiting nowThis study tests an experimental drug called paltusotine against a placebo in 141 adults with carcinoid syndrome caused by neuroendocrine tumors. The goal is to see if paltusotine can reduce daily episodes of flushing and diarrhea, which are common symptoms. Participants will rec…
Matched conditions: CARCINOID
Phase: PHASE3 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Family study aims to unlock secrets of rare gut cancer
Knowledge-focused Recruiting nowThis study looks at families with a history of small bowel carcinoid cancer to understand how the disease develops and spreads. Researchers will follow up to 1,600 people, including those with the disease and their healthy relatives, using advanced imaging and blood tests every t…
Matched conditions: CARCINOID
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated May 17, 2026 05:29 UTC